---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-005523"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T23:00:49.042734+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Phio Pharma receives ~$2.5M from warrant exercise, issues new warrants

## Summary
- Gross proceeds ~$2.5M from exercise of 928,596 warrants at $2.00 and $2.485 per share.
- Holders issued new unregistered Series J (5-yr term) and Series K (24-mo term) warrants for up to 1,857,192 shares at $2.485/share.
- Holders paid additional $0.125 per new warrant ($232,149 aggregate) as part of inducement.
- H.C. Wainwright receives 7.5% cash fee and placement agent warrants for 69,645 shares.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001683168-25-005523
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000168316825005523/0001683168-25-005523-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000168316825005523/phio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-005523
- JSON: https://secwatch.observer/filing/0001683168-25-005523.json
- Plain text: https://secwatch.observer/filing/0001683168-25-005523.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.